← back to search

Orin Bloch

UC Davis Children's Hospital ·
Area of research
Genetics · Immunology
Research interest
Research interests include Glioma Diagnosis and Treatment, Meningioma and schwannoma management, Immune cells in cancer, and Cancer Immunotherapy and Biomarkers.
h-index
46
citations
7,379
works
214
NIH funding
primary concept
email

Recent publications

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022
Journal of the National Comprehensive Cancer Network 2023cited by 215position: middledoi
A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma
Science Translational Medicine 2021cited by 310position: middledoi
Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review
Journal of Neuro-Oncology 2021cited by 28position: contributordoi
Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
Clinical Cancer Research 2019cited by 217position: lastdoi
Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer
Cancer Immunology, Immunotherapy 2019cited by 52position: contributordoi
Systemic and local immunosuppression in patients with high-grade meningiomas
Cancer Immunology, Immunotherapy 2019cited by 49position: contributordoi
Lymphopenia predicts response to stereotactic radiosurgery in lung cancer patients with brain metastases
Journal of Neuro-Oncology 2019cited by 16position: contributordoi
The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma
OncoImmunology 2018cited by 111position: lastdoi
Stereotactic Radiosurgery for Neurosurgical Patients: A Historical Review and Current Perspectives
World Neurosurgery 2018cited by 31position: middledoi
Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy
Clinical Cancer Research 2017cited by 116position: firstdoi
ATIM-14. ALLIANCE A071101: A PHASE II RANDOMIZED TRIAL COMPARING THE EFFICACY OF HEAT SHOCK PROTEIN PEPTIDE COMPLEX-96 (HSPPC-96) VACCINE GIVEN WITH BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF SURGICALLY RESECTABLE RECURRENT GLIOBLASTOMA
Neuro-Oncology 2017cited by 32position: firstdoi
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma
Journal of neurosurgery 2015cited by 90position: lastdoi
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
Journal of Clinical Neuroscience 2015cited by 86position: middledoi
Newly diagnosed glioblastoma patients treated with an autologous heat shock protein peptide vaccine: PD-L1 expression and response to therapy.
Journal of Clinical Oncology 2015cited by 15position: firstdoi
Immunocompetent murine models for the study of glioblastoma immunotherapy
Journal of Translational Medicine 2014cited by 251position: middledoi
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review
Neuro-Oncology 2014cited by 205position: middledoi
What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients?
Journal of neurosurgery 2014cited by 74position: middledoi
Pigmented villonodular synovitis of the temporomandibular joint with intracranial extension: A case series and systematic review
Head & Neck 2014cited by 53position: lastdoi
Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
Clinical Cancer Research 2013cited by 461position: firstdoi
Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Neuro-Oncology 2013cited by 237position: firstdoi
Impact of extent of resection for recurrent glioblastoma on overall survival
Journal of neurosurgery 2012cited by 427position: firstdoi
Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis
Neuro-Oncology 2012cited by 96position: middledoi
Skull Base Chondrosarcoma
Neurosurgery Clinics of North America 2012cited by 83position: firstdoi
Lumboperitoneal shunts for the treatment of normal pressure hydrocephalus
Journal of Clinical Neuroscience 2012cited by 52position: firstdoi
Fractionated radiotherapy for optic nerve sheath meningiomas
Journal of Clinical Neuroscience 2012cited by 51position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew T. Parsa · Neurological Surgery15 papers (2012–2019)Matthew Z. Sun · University of California, Los Angeles6 papers (2012–2015)Michael Safaee · University of Southern California5 papers (2012–2015)Gurvinder Kaur · Indian Institute of Science Education and Research Mohali5 papers (2012–2019)Jeffrey N. Bruce · Columbia University Irving Medical Center4 papers (2013–2017)Rajwant Kaur · St. Joseph Medical Center4 papers (2013–2019)Michael W. McDermott · University of California, San Francisco4 papers (2012–2014) · 4 papers (2019–2021)C. David James · Northwestern University3 papers (2014–2019)Tae-Min Oh · Pusan National University3 papers (2014–2015)Jeffrey J. Raizer · Northwestern University3 papers (2015–2017)Eli T. Sayegh · Brigham and Women's Hospital3 papers (2014–2015)Manish K. Aghi · Pediatric Brain Tumor Foundation2 papers (2012–2013)Dorina Veliceasa · University of Illinois Chicago2 papers (2018–2019)Jennifer Clarke · Elmhurst Hospital Center2 papers (2013–2017)Joseph D. DiDomenico · Neurological Surgery2 papers (2018–2019)Ricardo J. Komotar · University of Miami2 papers (2015–2017)Michael E. Ivan · Universitas Majalengka2 papers (2014–2015)Michael E. Sughrue · Allen Institute for Brain Science2 papers (2015–2017)Leonel Ampie · Georgetown University2 papers (2018–2019)